ConductScience.org, home

Paper71400

Polymorphic hydroxylation of Debrisoquine in man.

Mahgoub A and 4 others. Lancet, 1977. Cited by 1,087 papers, by iCite.

Cite this record

ConductScience Library. Polymorphic hydroxylation of Debrisoquine in man. Papers, record 71400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/71400

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Polymorphic hydroxylation of Debrisoquine in man.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1,087
iCite
Relative citation ratio, by iCite
33.3
iCite
Revised in PubMed
2019-06-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahgoub AA
2Idle JRJ R
3Dring LGL G
4Lancaster RR
5Smith RLR L

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DebrisoquinMajor topic
IsoquinolinesMajor topic
Administration, Oral
Adolescent
Adult
Alleles
Biological Availability
Chemical Phenomena
Chemistry
Child
Female
Genes, Recessive
Genotype
Humans
Hydroxylation
Male
Metabolism, Inborn Errors
Middle Aged

Source PubMed

Download CSV of topics

Cited by283

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,087 citations.

PMIDTitleJournalYearIn PapersSource
39054072Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.Pharmacol Rev2024https://conductscience.org/library/papers/39054072PubMed
38550951Maturing pharmacogenomic factors deliver improvements and cost efficiencies.Camb Prism Precis Med2023https://conductscience.org/library/papers/38550951PubMed
37996916Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling.Hum Genomics2023https://conductscience.org/library/papers/37996916PubMed
37667550Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research.Obes Rev2023https://conductscience.org/library/papers/37667550PubMed
37370844Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics.Cancers (Basel)2023https://conductscience.org/library/papers/37370844PubMed
36353484Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan.Front Pharmacol2022https://conductscience.org/library/papers/36353484PubMed
36015360Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone.Pharmaceutics2022https://conductscience.org/library/papers/36015360PubMed
35868640Drug Metabolism: A Half-Century Plus of Progress, Continued Needs, and New Opportunities.Drug Metab Dispos2023https://conductscience.org/library/papers/35868640PubMed
35373152From pharmacogenetics to pharmaco-omics: Milestones and future directions.HGG Adv2022https://conductscience.org/library/papers/35373152PubMed
35123571Frequencies of CYP2D6 genetic polymorphisms in Arab populations.Hum Genomics2022https://conductscience.org/library/papers/35123571PubMed
33424917Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.Front Genet2020https://conductscience.org/library/papers/33424917PubMed
33363564How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?Front Genet2020https://conductscience.org/library/papers/33363564PubMed
33143137A Review of the Important Role of CYP2D6 in Pharmacogenomics.Genes (Basel)2020https://conductscience.org/library/papers/33143137PubMed
32916938Precision Medicine: Steps along the Road to Combat Human Cancer.Cells2020https://conductscience.org/library/papers/32916938PubMed
32848197Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists.Pharmacogenomics J2021https://conductscience.org/library/papers/32848197PubMed
32837681A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.Toxicol Res2021https://conductscience.org/library/papers/32837681PubMed
31648367Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responses.Br J Pharmacol2020https://conductscience.org/library/papers/31648367PubMed
31544239PharmVar GeneFocus: CYP2D6.Clin Pharmacol Ther2020https://conductscience.org/library/papers/31544239PubMed
31283429Gene-Based Dose Optimization in Children.Annu Rev Pharmacol Toxicol2020https://conductscience.org/library/papers/31283429PubMed
30677473Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.Pharmacol Ther2019https://conductscience.org/library/papers/30677473PubMed

See all 283 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/71400

GET https://conductscience.org/api/papers/v1/71400/cited_by?page=2